Endeavor

CAR T Effective as First-Line Therapy for High-Risk Lymphoma Patients

New three-year data from the phase 2 ZUMA-12 trial finds durable responses

FDA Investigating ‘Serious Risk’ of Malignancy After CAR T Therapy

Benefits of the treatment still outweigh its risks, experts say

Actor Sam Neill Shares Blood Cancer Update

The “Jurassic Park” actor is in remission but expects his angioimmunoblastic T-cell lymphoma to return

Dick Vitale Diagnosed with Vocal Cord Cancer

This is the sports analyst’s third bout with cancer

Hematologist Trains at Moffitt, Hoping to Benefit Armenians

Through a visiting physician program, a doctor is learning the intricacies of an allogeneic BMT procedure and care to help his home country

Moffitt’s Blood Cancer Experts Share the Latest Research and Treatment Advances

The American Society of Hematology annual meeting is the largest event highlighting blood malignancies and disorders.

Can Bridging Radiation Therapy Increase Success of CAR T?

Moffitt study finds radiation prior to CAR T may increase survival in high-risk patients

Moffitt Experts Help Shape Breast Screening Guidelines for Transgender Patients

Physicians now have a tool to better determine when advanced imaging is needed

Jane Fonda Shares Non-Hodgkin Lymphoma Diagnosis

Treatment for the blood cancer is usually successful and produces mild side effects